Market Research Reports

Price range (USD)
$450 up to $22,000

Strategic Intelligence & Industry Research

Explore our library of analyst-validated market research reports. Our intelligence covers critical industry trends, competitive landscapes, and data-driven market forecasts to support your strategic decision-making.

Can’t find the report you need? If our syndicated library doesn’t have the precise data point or scope you are looking for, we provide custom research services designed to deliver the exact intelligence your organization requires.

Displaying 1 - 12 of 190 reports match your search
Navadhi Market Research · Pharmaceuticals
On demand

Global Metformin HCl Drugs Market Strategic Research Report

The global Metformin HCl drugs market stood at approximately 2.1 billion USD in 2024, positioned as one of the most commercially significant oral antidiabetic segmen…

$2.1B
2025
$3B
2032
▲ 5%CAGR2025–2032
5% CAGR $2.1B in 2025 150 pages Global
$3,500.00 from
Forecast $3B by 2032
View report
Navadhi Market Research · Pharmaceuticals
On demand

Global GLP-1 Receptor Agonist Oral Formulation Market Strategic Research Report

The global GLP-1 receptor agonist oral formulation market represents one of the most consequential pharmaceutical segments to emerge in the past decade, driven by th…

$6.8B
2025
$28B
2032
▲ 22.4%CAGR2025–2032
22.4% CAGR $6.8B in 2025 Global
$3,500.00 from
Forecast $28B by 2032
View report
Navadhi Market Research · Pharmaceuticals
On demand

Global Peptide Therapeutics for Cardiovascular and Metabolic Co-morbidities Market Strategic Research Report

The global peptide therapeutics market for cardiovascular and metabolic co-morbidities represents one of the most consequential intersections of pharmaceutical innov…

$38.6B
2025
$87.5B
2032
▲ 12.4%CAGR2025–2032
12.4% CAGR $38.6B in 2025 Global
$3,500.00 from
Forecast $87.5B by 2032
View report
Navadhi Market Research · Pharmaceuticals
On demand

Global Next-Generation Dual and Triple Incretin Agonists Market Strategic Research Report

The global next-generation dual and triple incretin agonist market represents one of the most consequential therapeutic inflection points in modern endocrinology and…

$28.4B
2025
$119.6B
2032
▲ 22.8%CAGR2025–2032
22.8% CAGR $28.4B in 2025 Global
$3,500.00 from
Forecast $119.6B by 2032
View report
Navadhi Market Research · Pharmaceuticals
On demand

Global Non-Alcoholic Steatohepatitis (NASH/MASH) Therapeutics Market Strategic Research Report

The global non-alcoholic steatohepatitis (NASH/MASH) therapeutics market represents one of the most consequential unmet medical needs in hepatology, with the market …

$2.1B
2025
$12.1B
2032
▲ 28.4%CAGR2025–2032
28.4% CAGR $2.1B in 2025 Global
$3,500.00 from
Forecast $12.1B by 2032
View report
Navadhi Market Research · Pharmaceuticals
On demand

Global Long-Acting Anti-Obesity Therapeutics Market Strategic Research Report

The global long-acting anti-obesity therapeutics market has emerged as one of the most commercially consequential segments in modern pharmacology, valued at approxim…

$18.4B
2025
$82B
2032
▲ 23.8%CAGR2025–2032
23.8% CAGR $18.4B in 2025 Global
$3,500.00 from
Forecast $82B by 2032
View report
Navadhi Market Research · Pharmaceuticals
On demand

Global Polycystic Ovarian Syndrome Targeted Therapeutics Market Strategic Research Report

Polycystic ovarian syndrome (PCOS) is the most prevalent endocrine disorder among women of reproductive age, affecting an estimated 8–13% of the global female popula…

$4.8B
2025
$8.4B
2032
▲ 8.3%CAGR2025–2032
8.3% CAGR $4.8B in 2025 Global
$3,500.00 from
Forecast $8.4B by 2032
View report
Navadhi Market Research · Pharmaceuticals
On demand

Global Oligonucleotide Therapeutics Solid-Phase Synthesis Market Strategic Research Report

The global oligonucleotide therapeutics solid-phase synthesis market occupied a pivotal position at the intersection of advanced chemistry and next-generation medici…

$2.8B
2025
$6.3B
2032
▲ 12.3%CAGR2025–2032
12.3% CAGR $2.8B in 2025 Global
$3,500.00 from
Forecast $6.3B by 2032
View report
Navadhi Market Research · Pharmaceuticals
On demand

Global Oligonucleotide Therapeutic Raw Material Phosphoramidite Market Strategic Research Report

The global oligonucleotide therapeutic raw material phosphoramidite market occupies a strategically critical position within the broader nucleic acid therapeutics su…

$1.42B
2025
$3.4B
2032
▲ 13.2%CAGR2025–2032
13.2% CAGR $1.42B in 2025 Global
$3,500.00 from
Forecast $3.4B by 2032
View report
Navadhi Market Research · Pharmaceuticals
On demand

Global Oral GLP-1 Receptor Agonists Market Strategic Research Report

The global oral GLP-1 receptor agonist market sits at the intersection of one of medicine's most consequential therapeutic shifts and a decades-long unmet patient ne…

$4.8B
2025
$29.6B
2032
▲ 29.7%CAGR2025–2032
29.7% CAGR $4.8B in 2025 Global
$3,500.00 from
Forecast $29.6B by 2032
View report
Navadhi Market Research · Pharmaceuticals
On demand

Global RNAi Therapeutics for Rare Genetic Disorders Market Strategic Research Report

The global RNA interference (RNAi) therapeutics market for rare genetic disorders represents one of the most scientifically consequential segments within precision m…

$4.8B
2025
$12.5B
2032
▲ 14.6%CAGR2025–2032
14.6% CAGR $4.8B in 2025 Global
$3,500.00 from
Forecast $12.5B by 2032
View report
Navadhi Market Research · Pharmaceuticals
On demand

Global Mitochondrial Medicine and Metabolic Reprogramming Therapeutics Market Strategic Research Report

The global mitochondrial medicine and metabolic reprogramming therapeutics market occupies a strategically critical position at the intersection of rare disease trea…

$1.38B
2025
$3.5B
2032
▲ 14.4%CAGR2025–2032
14.4% CAGR $1.38B in 2025 Global
$3,500.00 from
Forecast $3.5B by 2032
View report